Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: A randomised controlled trial

Lancet

Volumn 355, Issue 9216, 2000, Pages 1665-1669

  Moayyedi, Paul ^a   Feltbower, Richard ^b   Brown, Julia ^b   Mason, Su ^b   Mason, James ^c   Nathan, Jackie ^b   Richards, I D Gerald ^b   Dowell, Anthony C ^d   Axon, Anthony T R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; CLARITHROMYCIN; OMEPRAZOLE; PLACEBO; TINIDAZOLE; UREA;

ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NONHUMAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 0034643637     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02236-4     Document Type: Article

References (25)

1. Moayyedi P, Axon ATR. Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: the case for. Br Med Bull 1998; 54: 243-50.
2. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut 1994; 35: 619-24.
3. Axon ATR. Duodenal ulcer: the villain unmasked? BMJ 1991; 302: 919-21.
4. Talley NJ, Hunt RH. What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H pylori being associated with dyspeptic symptoms. Gastroenterology 1997; 113: S67-77.
5. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. Arch Intern Med 1998; 158: 1427-33.
6. Rosenstock S, Kay L, Rosenstock C, Andersen LP, Bonnevie O, Jorgensen T. Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut 1997; 41: 169-76.
7. McColl KEL, Morrison C, Woodward M. Contribution of H. pylori to dyspepsia and anti-secretory medication usage in a general population. Gut 1998; 42: A4(abstr).
8. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348: 150-54.
9. Walt B, Kerr G. Can eradicating Hpylori prevent gastric cancer? Lancet 1998; 351: 887.
10. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol Suppl 1996; 220: 23-26.
11. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-47.
12. Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998; 12: 1257-62.
13. Dupuy HJ. The Psychological General Well-being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. USA: Le Jacq Publishing, 1984: 170-83.
14. Moayyedi P, Braunholtz D, Heminbrough E, et al. Do patients need to fast for a 13C-urea breath test? Eur J Gastroenterol Hepatol 1997; 9: 275-77.
15. Mason J, Moayyedi P, Young PJ, et al. Population-based and opportunistic screening and eradication of Helicobacter pylori: an analysis using trial baseline data. Int J Technol Assess Health Care 1999; 15: 649-60.
16. McColl K, Murray L, el-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 1869-74.
17. Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999; 341: 1106-11.
18. Vaira D, Miglioli M, Mule P, et al. Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut 1994; 35: 309-12.
19. Parente F, Maconi G, Sangaletti O, et al. Prevalence of Helicobacter pylori infection and related gastroduodenal lesions in spouses of Helicobacter pylori positive patients with duodenal ulcer. Gut 1996; 39: 629-33.
20. Hosking SW, Ling TK, Chung SC, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without antacid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
21. Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut 1996; 38: 822-25.
22. Labenz J, Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut 1997; 41: 277-80.
23. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-08.
24. Talley NJ, Janssens J, Lauritsen K, et al. No increase in reflux symptoms in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication: a randomized double-blind placebo-controlled trial. Digestion 1998; 59: 7 (abstr).
25. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046-52.